EUCTR2009-015538-30-DE
Active, not recruiting
Not Applicable
Effect of intranasal oxytocin on social approach in patients with social phobia and healthy control - OXT_fMRT
Rheinisch-Westfälisch Technische Hochschule Aachen0 sitesFebruary 22, 2010
ConditionsThe effect of oxytocin is investigated in social processing of social phobic patient and healthy controlsMedDRA version: 12.0Level: LLTClassification code 10041250Term: Social phobia
DrugsSyntocinon®
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- The effect of oxytocin is investigated in social processing of social phobic patient and healthy controls
- Sponsor
- Rheinisch-Westfälisch Technische Hochschule Aachen
- Status
- Active, not recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18 and 45,
- •Full capacity to understand and execute instructions of the study,
- •For patients: diagnosis of social phobia according to ICD\-10 using a minimal score of 19 in the Social Phobia Inventory (SPIN, patient assessment) and 55 points in the Liebowitz Anxiety Scale (LAS, assessment by interviewer)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Sinistrality
- •Neurological or Somatic illness affecting the cerebral function (e.g. Parkinsons Disease, Epilepsy, Multiple Sclerosis, Brain Tumor)
- •Psychiatric disorder according to ICD\-10\-WHO F0\-F3, F8
- •Psychiatric disorder according to ICD\-10\-WHO F (applicable in patients only in untreated or if acute occurrence in the last six months
- •Exclusion criteria of MRI (incorporated metal)
- •Positive drug test
- •Consumption of centrally acting substances
- •persons commited governmental or legaly to an institution
- •Additionally in women: current of former pregnancy,
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Effect of intranasal oxytocin on social approach in patients with social phobia and healthy controlF40.1Social phobiasDRKS00000403Rheinisch-Westfälische Technische Hochschule Aachenvertretn durch das CTC-A derMedizinischen Fakultät der RWTH Aachen96
Completed
Early Phase 1
Methadone Oxytocin OptionSubstance AbuseOpioid DependenceMethadone TreatmentNCT01728909University of California, San Francisco64
Completed
Phase 2
Oxytocin Administration in BDD and OCDBody Dysmorphic DisorderObsessive-compulsive DisorderNCT02671266Massachusetts General Hospital41
Completed
Phase 1
Oxytocin Treatment of Social Cognitive and Functional Deficits in SchizophreniaSchizophreniaSchizoaffective DisorderNCT01394471University of North Carolina, Chapel Hill68
Completed
Not Applicable
The Influence of Intranasal Oxytocin on CommunicationHealthyNCT02415920University of British Columbia50